Skip to content

Content Library

Access exclusive news and content from the NDD Europe summit as well as the rest of the CNS series and the wider CNS community

Delving into the Role of Public Private Partnerships in Shaping the Landscape to Enable Precision Medicine for Neurodegeneration

A presentation by Diane Stephenson, PhD, Exceutive Director, Critical Path for Parkinson's


Using Clinical Insights in Protein Misfolding Disease to Improve the Translational Value of Preclinical Research

A presentation by Jonathan M. Levenson, PhD, Proclara Biosciences


Improving the use of existing animal models of neurodegeneration in early drug discovery

A presentation by Diana L. Price, PhD, Senior Director Neuroscience & In Vivo Pharmacology, NeuroPore Therapies


Receptor Mediated Transport of Biotherapeutics Across the Blood-Brain Barrier | Clinical Proof of Safety & Efficacy in Pediatric Patients with Severe MPS I

A presentation by ArmaGen